Status
Conditions
Treatments
About
This is a biomarker multi-centre study to validate an extraction method of fungal and bacterial DNA extracted from vaginal swabs from adult women with confirmed VVC.
The study population will consist of post-menarchal, pre-menopausal females, 18 years or older, seeking care for VVC symptoms.
Vaginal samples will be examined under a microscope for yeast forms (hyphae or pseudohyphae) or budding yeast. If the Investigator assesses that the patient has VVC, based on examination and the potassium hydroxide (KOH) test, two vaginal secretion samples will be collected by a vaginal swab. One sample will be cultured to verify the presence of Candida and the other will be used for sequencing analysis of the vaginal microbiome.
Samples from a total of 10 women are planned to be taken.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Adult women aged 18 years or older
Diagnosis of VVC, defined as having a white or creamy vaginal discharge plus the following findings:
Having decisional capacity and providing written informed consent
Signed informed consent and willing and able to comply with all study requirements
Exclusion criteria
None
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal